...
首页> 外文期刊>Journal of Hainan Medical University >Effect of the Jianpibushen Prescription-containing serum on the colon cancer cell growth and angiogenesis
【24h】

Effect of the Jianpibushen Prescription-containing serum on the colon cancer cell growth and angiogenesis

机译:健脾补肾方药血清对结肠癌细胞生长和血管生成的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: To study the effect of Jianpibushen Prescription-containing serum on the coloncancer cell growth and angiogenesis. Methods: SD male rats were taken and given intragastricadministration of Jianpibushen Prescription, and arterial blood was collected after 1 week toprepare drug-containing serum; colon cancer cell line HCT116 was cultured and divided intotwo groups. The intervention group was treated with DMEM containing 10% drug-containingserum, and the control group was treated with DMEM containing 10% drug-free serum.After 24 h of treatment, the mRNA expression of proliferation genes, invasion genes andangiogenesis genes in cells were measured. Results: EZH2, USP22, Nanog, FAK, CDC37,HOXB9, TROP2, ELMO3, c-met, HIF-1α, VEGF and Ang-2 mRNA expression in interventiongroup of colon cancer cells were significantly lower than those in control group while ASPP2,MS4A12, TWEAK and Fn14 mRNA expression were significantly higher than those in controlgroup. Conclusion: Jianpibushen Prescription-containing serum has inhibitory effect on thecolon cancer cell proliferation and invasion as well as angiogenesis.
机译:目的:探讨健脾补肾方药对结肠癌细胞生长和血管生成的影响。方法:SD雄性大鼠,服用健脾补肾方胃内给药,托普含药血清1周后采集动脉血。培养结肠癌细胞系HCT116,分为两组。干预组用含10%含药血清的DMEM治疗,对照组用含10%无药血清的DMEM治疗。治疗24小时后,细胞中增殖基因,侵袭基因和血管生成基因的mRNA表达测量。结果:结肠癌细胞干预组中EZH2,USP22,Nanog,FAK,CDC37,HOXB9,TROP2,ELMO3,c-met,HIF-1α,VEGF和Ang-2 mRNA的表达均显着低于对照组,而ASPP2, MS4A12,TWEAK和Fn14 mRNA的表达均明显高于对照组。结论:健脾补肾方含血清可抑制结肠癌细胞的增殖,侵袭和血管生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号